AI English summary of an SEC filing — figures as filed
A. O. Smith disclosed on May 19, 2026 that it has selected Carrie Anderson as Executive Vice President and Chief Financial Officer, effective July 1, 2026.
Key points
AI summaryA. O. Smith disclosed on May 19, 2026 that it has selected Carrie Anderson as Executive Vice President and Chief Financial Officer, effective July 1, 2026.
The company said Anderson will succeed Charles T. Lauber, who has decided to retire. Lauber will temporarily continue his employment with the company after July 1, 2026 until his retirement to facilitate the transition.
A. O. Smith said Anderson, age 57, served as executive vice president and chief financial officer of The Campbell's Company from January 2023 to October 2025 and held the same position at Integra LifeSciences from June 2019 to January 2023.
The company said the Personnel and Compensation Committee approved an award of restricted stock units to Anderson with a value of $1,500,000 as an incentive for her to join the company, which will vest 3 years after the grant date. She will also receive relocation assistance, including a special allowance of two months of salary to cover incidental expenses.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Carrie Anderson Named Chief Financial Officer
A. O. Smith disclosed on May 19, 2026 that it has selected Carrie Anderson as Executive Vice President and Chief Financial Officer, effective July 1, 2026.
Source · Based on the filing body and exhibits
Charles T. Lauber Retirement and Transition Period
The company said Anderson will succeed Charles T. Lauber, who has decided to retire. Lauber will temporarily continue his employment with the company after July 1, 2026 until his retirement to facilitate the transition.
Source · Based on the filing body and exhibits
Anderson's Career Background
A. O. Smith said Anderson, age 57, served as executive vice president and chief financial officer of The Campbell's Company from January 2023 to October 2025 and held the same position at Integra LifeSciences from June 2019 to January 2023.
Source · Based on the filing body and exhibits
Sign-On Incentive and Relocation Assistance
The company said the Personnel and Compensation Committee approved an award of restricted stock units to Anderson with a value of $1,500,000 as an incentive for her to join the company, which will vest 3 years after the grant date. She will also receive relocation assistance, including a special allowance of two months of salary to cover incidental expenses.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…